乳がん診断の世界市場2020-2026:診断種類別(イオン化乳房画像技術、非イオン化画像技術)、エンドユーザー別、地域別

◆英語タイトル:Global Breast Cancer Diagnostics Market Size study, by Diagnostic Type (Ionizing breast imaging technologies, Non-ionizing imaging technologies), by End-User (Hospitals, Cancer Research centers/institutes, Diagnostic Clinical Laboratories, Ambulatory Surgical centers) and Regional Forecasts 2020-2026
◆商品コード:BZW20JN001
◆発行会社(リサーチ会社):Bizwit Research & Consulting
◆発行日:2020年4月10日
◆ページ数:約200
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single User(1名様閲覧用、印刷不可)USD4,950 ⇒換算¥514,800見積依頼/購入/質問フォーム
Enterprisewide(同一法人内共有可)USD6,250 ⇒換算¥650,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はBizwit Research & Consulting社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Bizwit Research & Consulting社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本調査レポートでは、乳がん診断の世界市場について調査・分析し、エグゼクティブサマリー、市場定義・範囲、市場動向、産業分析、診断種類別(イオン化乳房画像技術、非イオン化画像技術)分析、エンドユーザー別分析、地域別分析、競争状況などを含め、次の構成でお届け致します。
・エグゼクティブサマリー
・市場定義・範囲
・市場動向
・産業分析
・乳がん診断の世界市場:診断種類別(イオン化乳房画像技術、非イオン化画像技術)
・乳がん診断の世界市場:エンドユーザー別
・乳がん診断の世界市場:地域別
・競争状況
【レポートの概要】

Global Breast Cancer Diagnostics Market is valued approximately USD 5.0 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 7.8% over the forecast period 2020-2026. Breast cancer is a malignant tumor formed in the breast cells that can spread into the whole parts of the body. It is diagnosed with the use of several tests to locate the site of initiation and the spread of the tumor to several parts of the body. At the initial stage, it can be diagnosed through certain screening tests such as yearly mammograms, MRI and CT scan. Increasing incidence of breast cancer among women, growing number of approvals for breast cancer diagnosis technologies, and favorable reimbursement framework for breast cancer diagnosis are the few factors responsible for high CAGR of the market over the forecast period. According to the World Cancer Research Fund International (WCRFI), breast cancer is the most common form of cancer in women worldwide with an average 2million new cases being detected every year. American Cancer Research Society (ACRS) anticipates by 2030, that incident rate of breast cancer is expected to reach over 9.9 million cases with over 5.5 million annual deaths, primarily due to aging population. Similarly, as per the European Breast Cancer Coalition, incidence in the EU-28 in 2018 was estimated to be around 404,920. This, in turn, is anticipated to accelerate the demand of breast cancer diagnostics around the world. However, high installation cost of devices and side effects of radiation are the few factors expected to impede the growth of the market over the forecast period of 2020-2026.

The regional analysis of global Breast Cancer Diagnostics market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the high patient awareness, well-established diagnostic infrastructure, and the early adoption of technologically advanced imaging systems in the region. However, Asia-Pacific is anticipated to exhibit highest growth rate / CAGR over the forecast period 2020-2026, due to rising incidence of breast cancer and rapidly improving healthcare infrastructure in the countries like China and India.

Major market player included in this report are:
Hologic Inc.
GE Healthcare
Phillips Healthcare
Fujifilm Holdings Corporation
Gamma Medica Inc.
Toshiba Corporation
Aurora Imaging Technology Inc.
Dilion Technologies Inc.
Genomic Health
NanoString Technologies, Inc.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Diagnostic Type:
Ionizing breast imaging technologies
Non-ionizing imaging technologies

By End-User:
Hospitals
Cancer research centers/institutes
Diagnostic Clinical laboratories
Ambulatory Surgical centers

By Region:
North America
U.S.
Canada
Europe
UK
Germany
Asia Pacific
China
India
Japan
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2016, 2017, 2018
Base year – 2019
Forecast period – 2020 to 2026

Target Audience of the Global Breast Cancer Diagnostics Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors

【レポートの目次】

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2018-2026 (USD Billion)
1.2.1. Breast Cancer Diagnostics Market, by Region, 2018-2026 (USD Billion)
1.2.2. Breast Cancer Diagnostics Market, by Diagnostic Type, 2018-2026 (USD Billion)
1.2.3. Breast Cancer Diagnostics Market, by End-User, 2018-2026 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Breast Cancer Diagnostics Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Breast Cancer Diagnostics Market Dynamics
3.1. Breast Cancer Diagnostics Market Impact Analysis (2018-2026)
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
Chapter 4. Global Breast Cancer Diagnostics Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2016-2026)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Breast Cancer Diagnostics Market, by Diagnostic Type
5.1. Market Snapshot
5.2. Global Breast Cancer Diagnostics Market by Diagnostic Type, Performance – Potential Analysis
5.3. Global Breast Cancer Diagnostics Market Estimates & Forecasts by Diagnostic Type 2016-2026 (USD Billion)
5.4. Breast Cancer Diagnostics Market, Sub Segment Analysis
5.4.1. Ionizing breast imaging technologies
5.4.2. Non-ionizing imaging technologies
Chapter 6. Global Breast Cancer Diagnostics Market, by End-User
6.1. Market Snapshot
6.2. Global Breast Cancer Diagnostics Market by End-User, Performance – Potential Analysis
6.3. Global Breast Cancer Diagnostics Market Estimates & Forecasts by End-User 2016-2026 (USD Billion)
6.4. Breast Cancer Diagnostics Market, Sub Segment Analysis
6.4.1. Hospitals
6.4.2. Cancer research centers/institutes
6.4.3. Diagnostic Clinical laboratories
6.4.4. Ambulatory Surgical centers
Chapter 7. Global Breast Cancer Diagnostics Market, Regional Analysis
7.1. Breast Cancer Diagnostics Market, Regional Market Snapshot
7.2. North America Breast Cancer Diagnostics Market
7.2.1. U.S. Breast Cancer Diagnostics Market
7.2.1.1. Diagnostic Type breakdown estimates & forecasts, 2016-2026
7.2.1.2. End-User breakdown estimates & forecasts, 2016-2026
7.2.2. Canada Breast Cancer Diagnostics Market
7.3. Europe Breast Cancer Diagnostics Market Snapshot
7.3.1. U.K. Breast Cancer Diagnostics Market
7.3.2. Germany Breast Cancer Diagnostics Market
7.3.3. Rest of Europe Breast Cancer Diagnostics Market
7.4. Asia-Pacific Breast Cancer Diagnostics Market Snapshot
7.4.1. China Breast Cancer Diagnostics Market
7.4.2. India Breast Cancer Diagnostics Market
7.4.3. Japan Breast Cancer Diagnostics Market
7.4.4. Rest of Asia Pacific Breast Cancer Diagnostics Market
7.5. Latin America Breast Cancer Diagnostics Market Snapshot
7.5.1. Brazil Breast Cancer Diagnostics Market
7.5.2. Mexico Breast Cancer Diagnostics Market
7.6. Rest of The World Breast Cancer Diagnostics Market
Chapter 8. Competitive Intelligence
8.1. Top Market Strategies
8.2. Company Profiles
8.2.1. Hologic Inc.
8.2.1.1. Key Information
8.2.1.2. Overview
8.2.1.3. Financial (Subject to Data Availability)
8.2.1.4. Product Summary
8.2.1.5. Recent Developments
8.2.2. GE Healthcare
8.2.3. Phillips Healthcare
8.2.4. Fujifilm Holdings Corporation
8.2.5. Gamma Medica Inc.
8.2.6. Toshiba Corporation
8.2.7. Aurora Imaging Technology Inc.
8.2.8. Dilion Technologies Inc.
8.2.9. Genomic Health
8.2.10. NanoString Technologies, Inc.
Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes
9.3. Research Assumption

List of Tables
TABLE 1. LIST OF SECONDARY SOURCES, USED IN THE STUDY OF GLOBAL BREAST CANCER DIAGNOSTICS MARKET
TABLE 2. LIST OF PRIMARY SOURCES, USED IN THE STUDY OF GLOBAL BREAST CANCER DIAGNOSTICS MARKET
TABLE 3. GLOBAL BREAST CANCER DIAGNOSTICS MARKET, REPORT SCOPE
TABLE 4. YEARS CONSIDERED FOR THE STUDY
TABLE 5. EXCHANGE RATES CONSIDERED
TABLE 6. GLOBAL BREAST CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY REGION 2016-2026 (USD BILLION)
TABLE 7. GLOBAL BREAST CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY DIAGNOSTIC TYPE 2016-2026 (USD BILLION)
TABLE 8. GLOBAL BREAST CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY END-USER 2016-2026 (USD BILLION)
TABLE 9. GLOBAL BREAST CANCER DIAGNOSTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 10. GLOBAL BREAST CANCER DIAGNOSTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 11. GLOBAL BREAST CANCER DIAGNOSTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 12. GLOBAL BREAST CANCER DIAGNOSTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 13. GLOBAL BREAST CANCER DIAGNOSTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 14. GLOBAL BREAST CANCER DIAGNOSTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 15. GLOBAL BREAST CANCER DIAGNOSTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 16. GLOBAL BREAST CANCER DIAGNOSTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 17. GLOBAL BREAST CANCER DIAGNOSTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 18. GLOBAL BREAST CANCER DIAGNOSTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 19. U.S. BREAST CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 20. U.S. BREAST CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 21. U.S. BREAST CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 22. CANADA BREAST CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 23. CANADA BREAST CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 24. CANADA BREAST CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 25. UK BREAST CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 26. UK BREAST CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 27. UK BREAST CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 28. GERMANY BREAST CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 29. GERMANY BREAST CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 30. GERMANY BREAST CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 31. ROE BREAST CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 32. ROE BREAST CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 33. ROE BREAST CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 34. CHINA BREAST CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 35. CHINA BREAST CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 36. CHINA BREAST CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 37. INDIA BREAST CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 38. INDIA BREAST CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 39. INDIA BREAST CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 40. JAPAN BREAST CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 41. JAPAN BREAST CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 42. JAPAN BREAST CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 43. ROAPAC BREAST CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 44. ROAPAC BREAST CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 45. ROAPAC BREAST CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 46. BRAZIL BREAST CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 47. BRAZIL BREAST CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 48. BRAZIL BREAST CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 49. MEXICO BREAST CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 50. MEXICO BREAST CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 51. MEXICO BREAST CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 52. ROLA BREAST CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 53. ROLA BREAST CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 54. ROLA BREAST CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 55. ROW BREAST CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 56. ROW BREAST CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 57. ROW BREAST CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[乳がん診断の世界市場2020-2026:診断種類別(イオン化乳房画像技術、非イオン化画像技術)、エンドユーザー別、地域別]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆